Comunicati Stampa
Salute e Benessere

Change to Novonesis' Board of Directors

Sharon James will not be seeking re-election to the Board of Directors of Novonesis at the upcoming annual general meeting in 2025 and will step down effectively on December 31, 2024. This decision reflects her desire to focus on personal priorities.  Cees de Jong, Chairman of the Board, comments:“Sharon James joined legacy Novozymes' Board of Directors in 2020. She has made significant contributions to Novozymes, now Novonesis, shaping the organization's direction. As leader of the...
Bagsvaerd, (informazione.it - comunicati stampa - salute e benessere)

Sharon James will not be seeking re-election to the Board of Directors of Novonesis at the upcoming annual general meeting in 2025 and will step down effectively on December 31, 2024. This decision reflects her desire to focus on personal priorities. 

:

Sharon James has expressed her gratitude for the opportunity to serve together with the Board and Management team with strong confidence in Novonesis' future leadership and strategic vision. 


Attachment


Per maggiori informazioni
Sito Web
novozymes.com
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Non disponibili